Livermore‑based Aalyria closed a $100M Series B at about a $1.3B valuation to scale its Spacetime orchestration software and Tightbeam laser terminals. Investors backed the spinout to speed commercial and government deployments.

Denver’s Xcimer says its KrF‑laser prototype could cut electricity costs and create hundreds of local jobs. The company has DOE backing and recent hardware milestones to show investors.

Generate Biomedicines filed to raise up to $425M in a Nasdaq IPO as it advances an AI‑designed antibody into Phase 3 and leans on partnerships with Amgen and Novartis.

A Honolulu summit this week will link startups, allied partners and military sustainment officials to fast track dual use technologies for Indo Pacific resilience.

A 12-story research tower at the University of Miami doubles Sylvester’s research footprint and stacks clinics over labs to speed trials and patient care. The Griffin building adds infusion bays, imaging and AI-driven labs for South Florida.

Missouri Botanical Garden is training AI with hyperspectral, space‑grade scans to identify herbarium specimens. The $14.4M RSI project aims to speed IDs and boost conservation work.

Beth Israel has started offering Clairity Breast, an FDA‑authorized AI that predicts five‑year breast cancer risk from routine mammograms. The tool is available now at BIDMC’s BreastCare Center.

A preprint from Ohio State shows influenza D replicates in human airway models and evades early immune responses. CDC‑journal authors warn that testing and surveillance are limited.

SpaceX is targeting a Falcon 9 launch from Cape Canaveral on Tuesday that will carry 29 Starlink satellites; the first stage will try for a sea landing aboard Just Read the Instructions.

A San Antonio nonprofit launched a bus-sized leukapheresis unit to collect immune cells for cell therapies, aiming to cut travel burdens for South Texas patients.

DOJ documents show Epstein’s money reached a UCSD lab after an introduction by Deepak Chopra; emails name a ‘telepathic’ autistic savant and a $25K payment.

A Seattle jury sided with Valve, finding inventor Leigh Rothschild violated state anti‑trolling and consumer‑protection laws and awarding Valve about $152,000.

A Froedtert surgeon used FDA‑approved Cytalux to make a tiny lung tumor glow during surgery, allowing a lung‑sparing removal. The technology may widen options for high‑risk patients.